StockData
Harmony Biosciences Holdings, Inc. logo

Harmony Biosciences Holdings, Inc. (HRMY) stock

HRMYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 18/3039% below fair value
$33.11+0.10 (+0.30%)

Close on Nov 18, 2026Market cap $1.93BP/E 10.7Yield –

Harmony Biosciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Harmony Biosciences's price to book ratio was 2.0× on Nov 11, 2026, against 2.4× a year earlier. Over the last 5 years it ranged from 1.9× to 16.4×, with a median of 3.7×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.0×−0.6
2025Dec 31, 20252.6×−0.7
2024Dec 31, 20243.3×−0.6
2023Dec 29, 20233.9×−5.6
2022Dec 30, 20229.5×−6.9
2021Dec 31, 202116.4×−5.4
2020Dec 31, 202021.8×–

More Harmony Biosciences figures

See a number that looks wrong?